Outlook Therapeutics Inc (OTLK)
8.60
+0.10
(+1.18%)
USD |
NASDAQ |
May 03, 16:00
8.57
-0.03
(-0.35%)
After-Hours: 20:00
Outlook Therapeutics Total Long Term Debt (Quarterly)
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2019 | 11.39M |
| June 30, 2019 | 11.42M |
| March 31, 2019 | 12.36M |
| December 31, 2018 | 13.81M |
| September 30, 2018 | 17.96M |
| June 30, 2018 | 17.65M |
| March 31, 2018 | 17.35M |
| December 31, 2017 | 17.07M |
| September 30, 2017 | 18.05M |
| June 30, 2017 | 16.36M |
| Date | Value |
|---|---|
| March 31, 2017 | 11.48M |
| December 31, 2016 | 9.848M |
| September 30, 2016 | 7.433M |
| June 30, 2016 | 7.735M |
| March 31, 2016 | 12.96M |
| December 31, 2015 | 13.63M |
| September 30, 2015 | 19.88M |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
11.39M
Minimum
Sep 2019
11.42M
Maximum
Jun 2019
11.41M
Average
11.41M
Median
Total Long Term Debt (Quarterly) Benchmarks
| Cutera Inc | 418.70M |
| Actinium Pharmaceuticals Inc | -- |
| GT Biopharma Inc | -- |
| Karyopharm Therapeutics Inc | 170.92M |
| Marinus Pharmaceuticals Inc | 72.97M |